脑梗死抗凝治疗解读ppt课件.ppt

* 这是这项研究中全球口服抗凝药物的使用情况调查结果，可以看到，北美及西欧地区，CHADS2评分大于等于2分的卒中高危患者口服抗凝药的使用比例达到65％左右，亚洲人群中这一比例为45％左右，而中国人群的抗凝比例很不乐观，只有10%，远远低于亚洲平均水平。 * * * Warfarin is more effective than ‘Aspirin’ at reducing the risk of stroke VKAs are currently the therapy of choice in patients with a medium–high risk of stroke, as reflected in the ACC/AHA/ESC and ACCP guidelines.1 A meta-analysis of 16 trials was conducted to assess the efficacy and safety of antithrombotic therapy for the prevention of stroke in AF.2 Of these 16 trials, warfarin was used exclusively in ten. In six of the trials, which involved 2,900 patients